Skip to main content

Advertisement

Log in

Reproducibility of AJCC Staging Parameters in Primary Cutaneous Melanoma: An Analysis of 4,924 Cases

  • Melanomas
  • Published:
Annals of Surgical Oncology Aims and scope Submit manuscript

Abstract

Background

Pathology reports are of critical importance for conveying information to clinicians who must make important management decisions for their patients. This study sought to assess and compare the precision, reproducibility, and completeness of external pathology reports and pathology reports generated by central review of each case in a large cohort of primary cutaneous melanoma patients.

Methods

Details of matched external pathology reports and corresponding review reports for 4,924 primary cutaneous invasive melanomas diagnosed and treated at Melanoma Institute Australia (MIA) between 2001 and 2011 were analyzed.

Results

Interobserver agreement was excellent for American Joint Committee on Cancer (AJCC) T staging parameters: Breslow thickness (intraclass correlation coefficient [ICC] 0.984), mitotic rate (ICC 0.833), and ulceration (kappa statistic [κ] 0.823). All three of these important pathologic variables were included in 92.4 and 66.9 % of review (MIA) and external (non-MIA) pathology reports, respectively. Completeness of MIA and non-MIA pathology reports for the three essential T-staging criteria increased significantly from 87.9 to 94.6 % (χ 2 = 9.1, df = 1, P = 0.003) and from 53.2 to 74.3 % (χ 2 = 35.0, df = 1, P < 0.001) over the 10-year study period. The AJCC N staging parameter of microsatellites was recorded in only 43 % of non-MIA reports and demonstrated moderate concordance (κ = 0.560).

Conclusions

Reproducibility and completeness of pathology reports for many important histopathologic features have improved in recent years. Nevertheless, the documentation of microsatellites remained poor in external pathology reports. To enhance the usefulness of the pathology report for the provision of optimal melanoma patient care, continued efforts to encourage pathologists to document its key features appear warranted.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Australian Cancer Network Melanoma Guidelines Revision Working Party. Clinical practice guidelines for the management of melanoma in Australia and New Zealand. Wellington: Cancer Council Australia and Australian Cancer Network, Sydney and New Zealand Guidelines Group; 2008.

  2. Thompson JF, Scolyer RA, Kefford RF. Cutaneous melanoma. Lancet. 2005;365:687–701.

    PubMed  CAS  Google Scholar 

  3. Balch CM, Gershenwald JE, Soong S, et al. Final version of 2009 AJCC melanoma staging and classification. J Clin Oncol. 2009;27:6199–206.

    Article  PubMed  Google Scholar 

  4. Hastrup N, Clemmensen OJ, Spaun E, Sondergaard K. Dysplastic naevus: histologic criteria and their inter-observer reproducibility. Histopathology. 1994;24:503–9.

    Article  PubMed  CAS  Google Scholar 

  5. Farmer ER, Gonin R, Hanna MP. Discordance in the histopathologic diagnosis of melanoma and melanocytic nevi between expert pathologists. Hum Pathol. 1996;27:528–31.

    Article  PubMed  CAS  Google Scholar 

  6. Shoo BA, Sagebriel RW, Kashani-Sabet M. Discordance in the histopathologic diagnosis of melanoma at a melanoma referral center. J Am Acad Dermatol. 2010;62:751–6.

    Article  PubMed  Google Scholar 

  7. Lodha S, Saggar S, Celebi JT, Silvers DN. Discordance in the histopathologic diagnosis of difficult melanocytic neoplasms in the clinical setting. J Cutan Pathol. 2008:35:349–52.

    Article  PubMed  Google Scholar 

  8. Altman DG. Practical statistics for medical research. London: Chapman and Hall; 1991.

    Google Scholar 

  9. Rosner B. Fundamentals of biostatistics. 4th ed. Belmont: Duxbury; 1995.

    Google Scholar 

  10. Suffin SC, Waisman J, Clark WH Jr, et al. Comparison of the classification by microscopic level (stage) of malignant melanoma by three independent groups of pathologists. Cancer. 1977;40:3112–4.

    Article  PubMed  CAS  Google Scholar 

  11. Larsen TE, Little JH, Orell SR, et al. International pathologists congruence survey on quantitation of malignant melanoma. Pathology. 1980;12:245–53.

    Article  PubMed  CAS  Google Scholar 

  12. Prade M, Sancho-Garnier H, Cesarini JP, et al. Difficulties encountered in the application of Clark classification and the Breslow thickness measurement in cutaneous malignant melanoma. Int J Cancer. 1980;26:159–63.

    Article  PubMed  CAS  Google Scholar 

  13. Holman CD, James IR, Heenan PJ, et al. An improved method of analysis of observer variation between pathologists. Histopathology. 1982;6:581–9.

    Article  PubMed  CAS  Google Scholar 

  14. Heenan PJ, Matz LR, Blackwell JB, et al. Inter-observer variation between pathologists in the classification of cutaneous malignant melanoma in Western Australia. Histopathology. 1984;8:717–29.

    Article  PubMed  CAS  Google Scholar 

  15. Colloby PS, West KP, Fletcher A. Observer variation in the measurement of Breslow depth and Clark’s level in thin cutaneous malignant melanoma. J Pathol. 1991;163:245–50.

    Article  PubMed  CAS  Google Scholar 

  16. Krieger N, Hiatt RA, Sagebiel RW, et al. Inter-observer variability among pathologists’ evaluation of malignant melanoma: effects upon an analytic study. J Clin Epidemiol. 1994;47:897–902.

    Article  PubMed  CAS  Google Scholar 

  17. Lock-Andersen J, Hou-Jensen K, Hansen JP, et al. Observer variation in histological classification of cutaneous malignant melanoma. Scand J Plast Reconstr Surg Hand Surg. 1995;29:141–8.

    Article  PubMed  CAS  Google Scholar 

  18. Corona R, Mele A, Amini M, et al. Interobserver variability on the histopathologic diagnosis of cutaneous melanoma and other pigmented skin lesions. J Clin Oncol. 1996;14:1218–23.

    PubMed  CAS  Google Scholar 

  19. Cook MG, Clarke TJ, Humphreys S, et al. The evaluation of diagnostic and prognostic criteria and the terminology of thin cutaneous malignant melanoma by the CRC Melanoma Pathology Panel. Histopathology. 1996;28:497–512.

    Article  PubMed  CAS  Google Scholar 

  20. Brochez L, Verhaeghe E, Grosshans E, Haneke E, Pierard G, Ruiter D, Naeyaert JM. Inter-observer variation in the histopathological diagnosis of clinically suspicious pigmented skin lesions. J Pathol. 2002;196:459–66.

    Article  PubMed  Google Scholar 

  21. Scolyer RA, Shaw HM, Thompson JF, et al. Interobserver reproducibility of histopathologic prognostic variables in primary cutaneous melanomas. Am J Surg Pathol. 2003;27:1571–6.

    Article  PubMed  Google Scholar 

  22. Murali R, Hughes MT, Fitzgerald P, Thompson JF, Scolyer RA. Interobserver variation in the histopathologic reporting of key prognostic parameters, particularly Clark level, affects pathologic staging of primary cutaneous melanoma. Ann Surg. 2009;249:641–7.

    Article  PubMed  Google Scholar 

  23. Harrist TJ, Rigel DS, Day CL Jr, et al. “Microscopic satellites” are more highly associated with regional lymph node metastases than is primary melanoma thickness. Cancer. 1984;53:2183–7.

    Article  PubMed  CAS  Google Scholar 

  24. Balch CM. Microscopic satellites around a primary melanoma: another piece of the puzzle in melanoma staging. Ann Surg Oncol. 2009;16:1092–4.

    Article  PubMed  Google Scholar 

  25. Kimsey TF, Cohen T, Patel A, et al. Microscopic satellitosis in patients with primary cutaneous melanoma: implications for nodal basin staging. Ann Surg Oncol. 2009;16:1176–83.

    Article  PubMed  Google Scholar 

  26. Rao UN, Ibrahim J, Flaherty LE, et al. Implications of microscopic satellites of the primary and extracapsular lymph node spread in patients with high-risk melanoma: pathologic corollary of Eastern Cooperative Oncology Group Trial E1690. J Clin Oncol. 2002;20:2053–7.

    Article  PubMed  CAS  Google Scholar 

  27. Shaikh L, Sagebiel RW, Ferreira CM, et al. The role of microsatellites as a prognostic factor in primary malignant melanoma. Arch Dermatol. 2005;141:739–42.

    Article  PubMed  CAS  Google Scholar 

  28. Kaur MR, Colloby PS, Martin-Clavijo A, Marsden JR. Melanoma histopathology reporting: are we complying with the National Minimum Dataset? J Clin Pathol. 2007;60;1121–3.

    Article  PubMed  Google Scholar 

  29. Thompson B, Austin R, Coory M, et al. Completeness of histopathology reporting of melanoma in a high-incidence geographical region. Dermatology. 2009;218:7–14.

    Article  PubMed  CAS  Google Scholar 

  30. Haydu LE, Holt PE, Karim RZ, et al. Quality of histopathological reporting on melanoma and influence of use of a synoptic template. Histopathology. 2010;56:768–74.

    Article  PubMed  Google Scholar 

  31. Karim RZ, van den Berg KS, Colman MH, McCarthy SW, Thompson JF, Scolyer RA. The advantage of using a synoptic pathology report format for cutaneous melanoma. Histopathology. 2008;52;130–8.

    Article  PubMed  CAS  Google Scholar 

  32. Scolyer RA, Judge MJ, Evans A, et al. Data set for pathology reporting of cutaneous invasive melanoma: recommendations from the International Collaboration on Cancer Reporting. Am J Surg Pathol. 2013 (in press).

Download references

Acknowledgment

Support in part by the Australian National Health and Medical Research Council and Cancer Institute New South Wales. RAS is supported by the Cancer Institute New South Wales Fellowship program. Assistance from colleagues at Melanoma Institute Australia and Royal Prince Alfred Hospital is also gratefully acknowledged.

Disclosure

The authors declare no conflict of interest.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to John F. Thompson MD, FRACS, FACS.

Electronic supplementary material

Below is the link to the electronic supplementary material.

Supplementary Fig. 3

Scatterplot demonstrating interobserver agreement of all valid cases (n = 4785) for Breslow thickness (mm) (TIFF 2353 kb)

Supplementary material 2 (DOCX 16 kb)

Rights and permissions

Reprints and permissions

About this article

Cite this article

Niebling, M.G., Haydu, L.E., Karim, R.Z. et al. Reproducibility of AJCC Staging Parameters in Primary Cutaneous Melanoma: An Analysis of 4,924 Cases. Ann Surg Oncol 20, 3969–3975 (2013). https://doi.org/10.1245/s10434-013-3092-5

Download citation

  • Received:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1245/s10434-013-3092-5

Keywords

Navigation